SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:gup.ub.gu.se/246996"
 

Sökning: id:"swepub:oai:gup.ub.gu.se/246996" > Impact of Type 1 Di...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003758naa a2200385 4500
001oai:gup.ub.gu.se/246996
003SwePub
008240910s2016 | |||||||||||000 ||eng|
0247 a https://gup.ub.gu.se/publication/2469962 URI
0247 a https://doi.org/10.1177/19322968166453652 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Barnard, Katharine4 aut
2451 0a Impact of Type 1 Diabetes Technology on Family Members/Significant Others of People With Diabetes.
264 c 2016-04-25
264 1b SAGE Publications,c 2016
520 a The aim was to explore the impact of diabetes-related technology to ensure that such devices are used in a way that returns maximum benefit from a medical and psychological perspective.Spouses and caregivers of people with type 1 diabetes were invited to complete an online questionnaire about their experiences with diabetes technologies used by their family members. Participants were recruited via the Glu online community website. Questions explored impact on daily living, frequency and severity of hypoglycemia, and diabetes-related distress.In all, 100 parents/caregivers and 74 partners participated in this survey. Average (mean) duration of living with a person with type 1 diabetes was 16 years (SD = 13) for partners, with duration of diabetes for children being 4.2 ± 3.2 years. Average duration of current therapy was 8.3 ± 7.3 years for adults and 3.4 ± 2.9 years for children. Of the participants, 86% partners and 82% parents/caregivers reported diabetes technology had made it easier for their family members to achieve blood glucose targets. Compared to partners, parents/caregivers reported more negative emotions (P < .001) and decreased well-being (P < .001) related to their family members type 1 diabetes. Diabetes-related distress was common, as was sleep disturbance associated with device alarms and fear of hypoglycemia. Reduced frequency and severity of hypoglycemia related to device use was reported by approximately half of participants.There is little doubt about the medical benefit of diabetes technologies and their uptake is increasing but some downsides were reported. Barriers to uptake of technologies lie beyond the mechanics of diabetes management. Supporting users in using diabetes technology to achieve the best possible glycemic control, in the context of their own life, is crucial. Furthermore, understanding these issues with input from the type 1 diabetes community including family members and caregivers will help innovation and design of new technology.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng
7001 a Crabtree, Vincent4 aut
7001 a Adolfsson, Peter,d 1963u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics4 aut0 (Swepub:gu)xadolp
7001 a Davies, Melanie4 aut
7001 a Kerr, David4 aut
7001 a Kraus, Amy4 aut
7001 a Gianferante, Danielle4 aut
7001 a Bevilacqua, Elizabeth4 aut
7001 a Serbedzija, George4 aut
7102 a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för pediatrik4 org
7730 t Journal of diabetes science and technologyd : SAGE Publicationsg 10:4, s. 824-30q 10:4<824-30x 1932-2968
8564 u https://journals.sagepub.com/doi/pdf/10.1177/1932296816645365
8564 8u https://gup.ub.gu.se/publication/246996
8564 8u https://doi.org/10.1177/1932296816645365

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy